Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - חפיפת שיער

Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - חפיפת שיער

Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - ריכוך השיער

Izraēla - ivrits - Ministry of Health

תעשיות חלאבין בעמ - לחות לעור

Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - חפיפת שיער

Izraēla - ivrits - Ministry of Health

שמעון שסטוביץ בעמ - רחצת הגוף

Izraēla - ivrits - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - ריכוך השיער

Izraēla - ivrits - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

Izraēla - ivrits - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

Izraēla - ivrits - Ministry of Health

שמעון שסטוביץ בעמ - בישום העור לאחר הגילוח